Pershing Square Bids €30.40 Per Share to Acquire Universal Music Group in $9.4B Deal 
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage 
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions 
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements 
First Western Ship Transits Strait of Hormuz Since Iran War Began 
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
Britain Courts Anthropic Amid US Defense Department Dispute 
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding? 
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering 
TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand 
UPS and Teamsters Reach Agreement to Limit Driver Severance Program 
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover 
TEMPLE CITY, Calif., Oct. 04, 2016 -- Fulgent Genetics (Nasdaq:FLGT) announced today the closing of its initial public offering of 4,200,000 shares of common stock at a public offering price of $9.00 per share, before underwriting discounts. All of the common stock was offered by Fulgent Genetics. The company’s common stock is listed on the Nasdaq Global Market under the symbol “FLGT.”
Credit Suisse Securities (USA) LLC and Piper Jaffray & Co. acted as joint book-running managers for the offering. Raymond James & Associates, Inc. acted as lead manager and BTIG, LLC acted as co-manager.
A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on September 28, 2016. The offering was made solely by means of a prospectus. A copy of the final prospectus relating to this offering may be obtained from: Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, Eleven Madison Avenue, New York, NY 10010, by telephone at +1-800-221-1037, or by email at [email protected]; or from Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Suite 800, Minneapolis, MN 55402, by telephone at +1-800-747-3924, or by email at [email protected].
This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
IR Contacts: Bob Jones 212-871-5570 [email protected] Chris Danne 415-217-5865 [email protected]
